What is the share price of Symbiotec Pharmalab Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Symbiotec Pharmalab Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Symbiotec Pharmalab?

The latest standalone P/E ratio of Symbiotec Pharmalab as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Symbiotec Pharmalab Ltd?

The latest standalone P/B ratio of Symbiotec Pharmalab Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Symbiotec Pharmalab Ltd?

The 52-week high of Symbiotec Pharmalab Ltd is Rs. and the 52-week low is Rs. .

Symbiotec Pharmalab Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Symbiotec Pharmalab Ltd
Brand: Symbiotec Pharmalab

Symbiotec Pharmalab Ltd

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0

TTM Sales

₹528 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

12.41%

Return on Capital Employed (ROCE)

15.75%

Return on Assets (ROA)

8.88%

Operating Profit Margin

21.3%

Net Profit Margin

13.2%

Gross Profit Margin

23%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

19.52%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

78.47%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹414 Cr.

Equity

₹0 Cr.

Face Value

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	16.2%	13.4%	14.7%	15.1%	14.5%	16.9%	29.1%	11.9%	0%	15.8%	-
Growth Parameters ⓘ
Sales ⓘ	389	419	438	410	528	531	623	634	564	674	528
Sales YoY Gr.	-	7.6%	4.6%	-6.4%	28.9%	0.7%	17.3%	1.8%	-11.1%	19.5%	-
Adj EPS ⓘ	6	5.3	8.5	7.9	8.9	13.3	24.5	11.3	4.4	15.6	0
YoY Gr.	-	-11.6%	60.7%	-6.2%	12.6%	48.8%	84.4%	-54%	-61.4%	258.3%	-
BVPS (₹) ⓘ	45	50	61.1	68.9	77.8	91	115.8	127.1	123.1	139.2	0
Adj Net Profit ⓘ	32.3	28.6	45.9	43.1	48.8	72.7	134	61.7	23.9	85.4	NAN
Cash Flow from Ops. ⓘ	28.5	19.2	52.3	48.3	43.7	109	158	23.5	93.4	147	-
Debt/CF from Ops. ⓘ	6.5	10.3	3.3	3.2	3.5	1.1	0.3	2.7	1.2	0.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.3%	5%	2.7%	19.5%
Adj EPS ⓘ	11.3%	11.8%	-13.9%	258.3%
BVPSⓘ	13.4%	12.4%	6.3%	13.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	14.1	11.1	15.2	12.2	12.2	15.7	23.7	9.3	3.5	11.9	0
Op. Profit Mgn % ⓘ	17	17.7	19.4	22.5	18.9	22.5	32.5	16.6	14.7	21.3	NAN
Net Profit Mgn % ⓘ	8.3	6.8	10.5	10.5	9.3	13.7	21.5	9.7	4.2	12.7	NAN
Debt to Equity ⓘ	0.8	0.7	0.5	0.4	0.4	0.2	0.1	0.1	0.2	0.1	-
Working Cap Days ⓘ	163	198	216	246	231	260	221	246	316	326	0
Cash Conv. Cycle ⓘ	56	84	100	135	127	136	101	137	179	112	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	389.06	418.52	437.66	409.61	527.77	531.19	622.86	633.85	563.59	673.61
Operating Expenses ⓘ +	327.80	346.25	354.36	318.97	432.04	411.80	420.50	528.55	483.49	530.67
Manufacturing Costs	14.20	24.01	47.33	37.03	43.51	45.20	57.37	55.59	61.57	69
Material Costs	253.10	249.25	230.49	202.32	303.37	257.03	266.09	354.23	289.79	321.57
Employee Cost	28.80	42.05	43.58	49.34	54.25	64.47	72.77	81.74	92.55	101.60
Other Costs ⓘ	31.71	30.94	32.97	30.29	30.90	45.11	24.26	36.99	39.58	38.50
Operating Profit ⓘ	61.27	72.27	83.30	90.64	95.73	119.39	202.37	105.30	80.09	142.94
Operating Profit Margin (%)	15.7%	17.3%	19.0%	22.1%	18.1%	22.5%	32.5%	16.6%	14.2%	21.2%
Other Income ⓘ +	9.84	3.13	6.71	7.59	4.86	3.17	9.01	5.65	12.37	19.76
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-64.57	0
Interest ⓘ	15.02	24.04	18.95	17.59	17.83	10.61	6.52	3.07	8.05	7.54
Depreciation ⓘ	10.80	15.37	18.50	20.16	20.12	21.16	22.18	25.11	27.62	37.26
Profit Before Tax ⓘ	45.29	35.99	52.56	60.48	62.64	90.79	182.67	82.77	-7.78	117.90
Tax ⓘ	14.92	8.75	3.86	18.49	16.54	18.27	47.11	21.04	14.88	28.95
Profit After Tax	30.37	27.24	48.70	41.99	46.10	72.52	135.56	61.73	-22.66	88.95
PAT Margin (%)	7.8%	6.5%	11.1%	10.3%	8.7%	13.7%	21.8%	9.7%	-4.0%	13.2%
Adjusted EPS (₹)	5.6	5.0	9.0	7.7	8.4	13.3	24.8	11.3	-4.1	16.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Symbiotec Pharmalab - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund +	244.27	271.51	332.22	374.25	425.23	497.83	633.35	695.18	672.81	761.14
Share Capital ⓘ	10.87	10.87	10.87	10.87	10.94	10.94	10.94	10.94	10.94	10.94
Reserves ⓘ	233.40	260.64	321.35	363.38	414.29	486.90	622.42	684.25	661.88	750.20
Debt +	171.50	182.02	153.84	132.92	144.26	117.50	46.41	63.25	106.67	51.25
Long Term Debt	47.04	38.08	30.19	12.62	5.68	2.47	1.46	0.73	1.41	1.12
Short Term Debt	124.46	143.94	123.64	120.30	138.58	115.03	44.95	62.52	105.26	50.13
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	70.60	90.35	80.13	64.47	124.83	108.02	109.82	84.88	86.61	226.92
Others Liabilities ⓘ	42.29	53.61	50.33	55.84	47.49	46.21	52.28	51.17	49.03	47.88
Total Liabilities ⓘ	528.65	597.50	616.51	627.47	741.80	769.55	841.87	894.48	915.12	1,087.19
Fixed Assets
Net Fixed Assets ⓘ +	186.23	224.82	239.40	227.01	222.89	229.62	247.58	266.09	265.65	323.82
Gross Block	217.28	270.95	257.82	265.60	281.60	309.01	348.53	391.57	418.23	513.66
Accumulated Depreciation	31.05	46.13	18.42	38.59	58.71	79.40	100.94	125.49	152.59	189.84
CWIP ⓘ	30.55	2.83	1.17	6.73	12.97	30.50	26.73	22.62	73.90	19.36
Investments ⓘ	102.42	99.68	103.31	105.56	111.33	110.39	122.59	130.17	65.60	42.25
Inventories	87.37	126.07	128.25	127.94	216.10	230.85	225.26	245.41	241.72	332.61
Trade Receivables	75.27	99.41	110.31	122.78	127.67	106.92	118.68	143.66	112.31	125.43
Cash Equivalents	10.60	9.13	3.36	5.82	8.32	28.54	41.14	6.32	2.83	6.27
Others Assets ⓘ	36.22	35.56	30.72	31.63	42.52	32.75	59.89	80.22	153.11	237.45
Total Assets ⓘ	528.65	597.50	616.51	627.47	741.80	769.55	841.87	894.48	915.12	1,087.19

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ +	28.49	19.17	52.27	48.32	43.74	109	157.70	23.51	93.35	147.46
PBT ⓘ	45.29	35.99	52.56	60.48	62.64	90.79	182.67	82.77	-7.78	117.90
Adjustment ⓘ	23.86	34.52	29.80	31.14	36.01	33.72	29.13	22.97	91.15	25.36
Changes in Working Capital ⓘ	-30.88	-46.38	-17.37	-27.91	-40.22	8.68	-11.57	-58.89	25.8	39.29
Tax Paid ⓘ	-9.79	-4.96	-12.72	-17.30	-13.25	-24.19	-42.53	-23.34	-15.82	-35.09
Cash Flow From Investing Activity ⓘ +	-88.39	-37.49	-7.62	-15.61	-26.97	-69.91	-78.99	-33.94	-132.50	-80.80
Capex	-84.98	-29.30	-35.18	-16	-23.70	-48.42	-41.51	-41.58	-71.75	-40.12
Net Investments	0	0	39.94	26.71	17.60	30.22	2.84	0.44	0	29.07
Others ⓘ	-3.40	-8.19	-12.38	-26.32	-20.87	-51.72	-40.32	7.20	-60.76	-69.76
Cash Flow From Financing Activity ⓘ +	70.13	-6.93	-44.34	-31.70	-14.19	-42.23	-79.04	14.84	36.53	-62.98
Net Proceeds from Shares ⓘ	0	0	0	0	5	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	-6.24	0	0	0	0	16.17	0	0
Interest Paid ⓘ	-12.67	-20.85	-17.80	-15.66	-16.98	-9.55	-5.67	-1.22	-7.04	-6.99
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	82.81	13.92	-20.30	-16.04	-2.21	-32.68	-73.38	-0.11	43.57	-55.99
Net Cash Flow ⓘ	10.24	-25.25	0.32	1	2.58	-3.14	-0.33	4.41	-2.62	3.67

Financial Ratio

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.26	10.56	16.13	11.89	11.53	15.71	23.97	9.29	-3.31	12.41
ROCE (%)	16.2	13.36	14.69	15.11	14.52	16.94	29.12	11.93	0.04	15.75
Asset Turnover Ratio	0.85	0.75	0.74	0.66	0.77	0.7	0.8	0.74	0.62	0.67
PAT to CFO Conversion(x)	0.94	0.7	1.07	1.15	0.95	1.5	1.16	0.38	N/A	1.66
Working Capital Days
Receivable Days	60.70	75.10	85.60	103.90	86.60	80.60	64.30	74	82.90	64.40
Inventory Days	72.90	91.70	103.70	114.10	119	153.60	130	132.80	157.70	155.60
Payable Days	97.60	117.90	135	130.40	113.90	165.30	149.40	100.30	108	177.90

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Symbiotec Pharmalab Ltd FAQs

The current trading price of Symbiotec Pharmalab on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Symbiotec Pharmalab stood at ₹0.00 Cr

The latest P/E ratio of Symbiotec Pharmalab as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Symbiotec Pharmalab as of 31-Dec-1969 is 0.00.

The 52-week high of Symbiotec Pharmalab is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Symbiotec Pharmalab is ₹528 ( Cr.) .

Data is not available for this company.

No data found

About Symbiotec Pharmalab Ltd

No data to display

Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Ltd

10 Year X-Ray :